Preprint Article Version 1 This version is not peer-reviewed

Antidiabetic and Renoprotective Effects of Acankoreagenin from the Leaves of Acanthopanax Gracilistylus in Streptozotocin-Induced Type I Diabetic Rats

Version 1 : Received: 20 October 2018 / Approved: 22 October 2018 / Online: 22 October 2018 (10:45:08 CEST)

How to cite: Yang, Y.; Lu, M.; Zou, Q.; Liu, X.; Hwang, E. Antidiabetic and Renoprotective Effects of Acankoreagenin from the Leaves of Acanthopanax Gracilistylus in Streptozotocin-Induced Type I Diabetic Rats. Preprints 2018, 2018100489 (doi: 10.20944/preprints201810.0489.v1). Yang, Y.; Lu, M.; Zou, Q.; Liu, X.; Hwang, E. Antidiabetic and Renoprotective Effects of Acankoreagenin from the Leaves of Acanthopanax Gracilistylus in Streptozotocin-Induced Type I Diabetic Rats. Preprints 2018, 2018100489 (doi: 10.20944/preprints201810.0489.v1).

Abstract

This present study was designed to find out whether the acankoreagenin showed the antidiabetic and renoprotective effects in streptozotocin (STZ)-induced diabetic nephropathy (DN) rats. Type I diabetes was induced by a single intraperitoneal injection of STZ (70 mg/kg). At the end of the experiment, rats were euthanized and serum/plasma was separated for the determination of glucose, insulin, glycated hemoglobin A1c (HbA1c), C-peptide, biochemical parameters, and kidney function. One kidney was used for determining glutathione, superoxide dismutas, malondialdehyde, and tumor necrosis factor-alpha levels. The other kidney and pancreas were used for histopathological studies and immunohistochemical measurement of transforming growth factor beta (TGF-β) or NF-κB. Acankoreagenin (2 mg/kg) treatments led to a significant reduction in blood glucose assessed via oral glucose tolerance test (OGTT) in diabetic rats at 2 h. The treatment also resulted in improved body weight, decreased HbA1c, restored lipid profile, and renal oxidative stress. By inhibiting NF-κB, the release of proinflammatory cytokines was suppressed and by inhibiting TGF-β, the renal fibrosis was suppressed in STZ-induced diabetic rat model. Histopathological injury was also observed in pancreatic and renal tissues. These findings support the beneficial effect of acankoreagenin treatment in DN, which could be attributed to its antidiabetic and renoprotective effects.

Subject Areas

diabetes mellitus; blood glucose; kidney; diabetic neuropathy; pancreas

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.